Document is current
Any future updates will be listed below
-
Authors
Guo, Shanshan
Bourova-Flin, Ekaterina
Rousseaux, Sophie
Chuffart, Florent
Peng, Lijun
Jing, Duohui
Mi, Jian-Qing
Khochbin, Saadi
Wang, Jin
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (No. 82270187)
Key Technologies Research and Development Program (No. 2023ZD0501300, No. 2023YFC2508900)
Alliance Nationale pour les Sciences de la Vie et de la Santé (the Cancer ITMO [Multi-Organisation Thematic Institute of the French Alliance for Life Sciences, Health (AVIESAN)] MIC program)
Agence Nationale de la Recherche (ANR-23-CE12-0028-01, ANR-23-CE14- 0050-02)
- License Information
-
More Information
Article History
Received: 17 January 2025
Accepted: 25 March 2025
First Online: 14 May 2025
Declarations
:
: All procedures performed in this study involving human samples were approved by the Ethics Review Committee of Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, and in accordance with the Declaration of Helsinki. Each patient included in this study, or their families, provided informed consent by signing a consent form permitting the use of biomaterials and clinical data for scientific research purposes.
: Not applicable.
: All the authors declare no competing interests.
